GSK to cut 130 jobs in Irish manufacturing
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline has reiterated its commitment to its Dungarvan consumer healthcare manufacturing site in Ireland after announcing that it will cut nearly 20% of its workforce there over the next three years.